References

Key articles

Lim WS, Baudouin SV, George RC, et al; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009 Oct;64(suppl 3):iii1-55.Full text external link opens in a new windowAbstract external link opens in a new window

Public Health England. Immunisation. Aug 2019 [internet publication].Full text external link opens in a new window

Public Health England. Pneumococcal: the green book, chapter 25. Jan 2018 [internet publication].Full text external link opens in a new window

Public Health England. Influenza: the green book, chapter 19. Apr 2019 [internet publication].Full text external link opens in a new window

National Institute for Health and Care Excellence. Pneumonia in adults: diagnosis and management. Sep 2019 [internet publication]. WITHDRAWN during COVID-19 pandemic.Full text external link opens in a new window

O'Driscoll BR, Howard LS, Earis J, et al. BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017 Jun;72 (Suppl 1):ii1-90.Abstract external link opens in a new window

Lim WS, Smith DL, Wise MP, et al. British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together. Thorax. 2015 Jul;70(7):698-700.Full text external link opens in a new windowAbstract external link opens in a new window

National Institute for Health and Care Excellence. Pneumonia (community-acquired): antimicrobial prescribing. Sep 2019 [internet publication].Full text external link opens in a new window

Stern A, Skalsky K, Avni T, et al. Corticosteroids for pneumonia. Cochrane Database Syst Rev. 2017 Dec 13;(12):CD007720.Full text external link opens in a new windowAbstract external link opens in a new window

Reference articles

1. Lim WS, Baudouin SV, George RC, et al; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009 Oct;64(suppl 3):iii1-55.Full text external link opens in a new windowAbstract external link opens in a new window

2. Simonetti AF, Viasus D, Garcia-Vidal C, et al. Management of community-acquired pneumonia in older adults. Ther Adv Infect Dis. 2014 Feb;2(1):3-16.Full text external link opens in a new windowAbstract external link opens in a new window

3. Masiá M, Gutiérrez F, Padilla S, et al. Clinical characterisation of pneumonia caused by atypical pathogens combining classic and novel predictors. Clin Microbiol Infect. 2007 Feb;13(2):153-61.Full text external link opens in a new windowAbstract external link opens in a new window

4. World Health Organization. The top 10 causes of death. May 2018 [internet publication].Full text external link opens in a new window

5. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 Mar 1;44(suppl 2):S27-72.Full text external link opens in a new windowAbstract external link opens in a new window

6. Torres A, Peetermans WE, Viegi G, et al. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax. 2013 Nov;68(11):1057-65.Full text external link opens in a new windowAbstract external link opens in a new window

7. Alimi Y, Lim WS, Lansbury L, et al. Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe. J Clin Virol. 2017 Oct;95:26-35.Abstract external link opens in a new window

8. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA. 1996 Jan 10;275(2):134-41.Abstract external link opens in a new window

9. Alkhayer M, Jenkins PF, Harrison BD. The outcome of community acquired pneumonia treated on the intensive care unit. Respir Med. 1990 Jan;84(1):13-6.Abstract external link opens in a new window

10. Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012 Jan;67(1):71-9.Abstract external link opens in a new window

11. Lin SH, Lai CC, Tan CK, et al. Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumoniae. Epidemiol Infect. 2011 Sep;139(9):1307-16.Abstract external link opens in a new window

12. Garcia-Vidal C, Ardanuy C, Tubau F, et al. Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes. Thorax. 2010 Jan;65(1):77-81.Abstract external link opens in a new window

13. Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among US adults. N Engl J Med. 2015 Jul 30;373(5):415-27.Full text external link opens in a new windowAbstract external link opens in a new window

14. Xu J, Murphy SL, Kochanek KD, et al. Deaths: final Data for 2016. Natl Vital Stat Rep. 2018 Jul;67(5):1-76.Abstract external link opens in a new window

15. Rice LB. Antimicrobial resistance in gram-positive bacteria. Am J Med. 2006 Jun;119(suppl 1):S11-9.Abstract external link opens in a new window

16. Cillóniz C, Ewig S, Polverino E, et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax. 2011 Apr;66(4):340-6.Full text external link opens in a new windowAbstract external link opens in a new window

17. Cillóniz C, Ewig S, Polverino E, et al. Community-acquired pneumonia in outpatients: aetiology and outcomes. Eur Respir J. 2012 Oct;40(4):931-8.Full text external link opens in a new windowAbstract external link opens in a new window

18. Cilloniz C, Torres A, Polverino E, et al. Community-acquired lung respiratory infections in HIV-infected patients: microbial aetiology and outcome. Eur Respir J. 2014 Jun;43(6):1698-708.Full text external link opens in a new windowAbstract external link opens in a new window

19. Almirall J, Boixeda R, Bolíbar I, et al. Differences in the etiology of community-acquired pneumonia according to site of care: a population-based study. Respir Med. 2007 Oct;101(10):2168-75.Full text external link opens in a new windowAbstract external link opens in a new window

20. Almirall J, Bolíbar I, Vidal J, et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J. 2000 Apr;15(4):757-63.Full text external link opens in a new windowAbstract external link opens in a new window

21. Marchello C, Dale AP, Thai TN, et al. Prevalence of atypical pathogens in patients with cough and community-acquired pneumonia: a meta-analysis. Ann Fam Med. 2016 Nov;14(6):552-66.Full text external link opens in a new windowAbstract external link opens in a new window

22. Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819-28.Abstract external link opens in a new window

23. Torres A, Barberán J, Falguera M, et al. Multidisciplinary guidelines for the management of community-acquired pneumonia [in Spanish]. Med Clin (Barc). 2013 Mar 2;140(5):223.Abstract external link opens in a new window

24. Mandell LA, Marrie TJ, Grossman RF, et al; The Canadian Community-Acquired Pneumonia Working Group. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis. 2000 Aug;31(2):383-421.Full text external link opens in a new windowAbstract external link opens in a new window

25. Hogerwerf L, DE Gier B, Baan B, et al. Chlamydia psittaci (psittacosis) as a cause of community-acquired pneumonia: a systematic review and meta-analysis. Epidemiol Infect. 2017 Nov;145(15):3096-105.Abstract external link opens in a new window

26. Spoorenberg SM, Bos WJ, van Hannen EJ, et al. Chlamydia psittaci: a relevant cause of community-acquired pneumonia in two Dutch hospitals. Neth J Med. 2016 Feb;74(2):75-81.Abstract external link opens in a new window

27. Ding C, Yang Z, Wang J, et al. Prevalence of Pseudomonas aeruginosa and antimicrobial-resistant Pseudomonas aeruginosa in patients with pneumonia in mainland China: a systematic review and meta-analysis. Int J Infect Dis. 2016 Aug;49:119-28.Full text external link opens in a new windowAbstract external link opens in a new window

28. Jokinen C, Heiskanen L, Juvonen H, et al. Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin Infect Dis. 2001 Apr 15;32(8):1141-54.Full text external link opens in a new windowAbstract external link opens in a new window

29. Jennings LC, Anderson TP, Beynon KA, et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax. 2008 Jan;63(1):42-8.Full text external link opens in a new windowAbstract external link opens in a new window

30. Burk M, El-Kersh K, Saad M, et al. Viral infection in community-acquired pneumonia: a systematic review and meta-analysis. Eur Respir Rev. 2016 Jun;25(140):178-88.Full text external link opens in a new windowAbstract external link opens in a new window

31. Wunderink RG, Waterer G. Advances in the causes and management of community acquired pneumonia in adults. BMJ. 2017 Jul 10;358:j2471.Abstract external link opens in a new window

32. Johansson N, Kalin M, Tiveljung-Lindell A, et al. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis. 2010 Jan 15;50(2):202-9.Full text external link opens in a new windowAbstract external link opens in a new window

33. Alcón A, Fàbregas N, Torres A. Pathophysiology of pneumonia. Clin Chest Med. 2005 Mar;26(1):39-46.Abstract external link opens in a new window

34. Rumbak MJ. The pathogenesis of ventilator-associated pneumonia. Semin Respir Crit Care Med. 2002 Oct;23(5):427-34.Abstract external link opens in a new window

35. Dickson RP, Erb-Downward JR, Huffnagle GB. Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis. Lancet Respir Med. 2014 Mar;2(3):238-46.Full text external link opens in a new windowAbstract external link opens in a new window

36. Cillóniz C, Polverino E, Ewig S, et al. Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. Chest. 2013 Sep;144(3):999-1007.Abstract external link opens in a new window

37. Polverino E, Dambrava P, Cillóniz C, et al. Nursing home-acquired pneumonia: a 10 year single-centre experience. Thorax. 2010 Apr;65(4):354-9.Full text external link opens in a new windowAbstract external link opens in a new window

38. Sund-Levander M, Ortqvist A, Grodzinsky E, et al. Morbidity, mortality and clinical presentation of nursing home-acquired pneumonia in a Swedish population. Scand J Infect Dis. 2003;35(5):306-10.Abstract external link opens in a new window

39. Molinos L, Clemente MG, Miranda B, et al. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease. J Infect. 2009 Jun;58(6):417-24.Abstract external link opens in a new window

40. Kohlhammer Y, Schwartz M, Raspe H, et al. Risk factors for community acquired pneumonia (CAP): a systematic review [in German]. Dtsch Med Wochenschr. 2005 Feb 25;130(8):381-6.Abstract external link opens in a new window

41. Gordin FM, Roediger MP, Girard PM, et al. Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption. Am J Respir Crit Care Med. 2008 Sep 15;178(6):630-6.Abstract external link opens in a new window

42. Bello S, Menéndez R, Torres A, et al. Tobacco smoking increases the risk for death from pneumococcal pneumonia. Chest. 2014 Oct;146(4):1029-37.Abstract external link opens in a new window

43. Almirall J, Serra-Prat M, Bolíbar I, et al. Passive smoking at home is a risk factor for community-acquired pneumonia in older adults: a population-based case-control study. BMJ Open. 2014 Jun 13;4(6):e005133.Full text external link opens in a new windowAbstract external link opens in a new window

44. Simou E, Britton J, Leonardi-Bee J. Alcohol and the risk of pneumonia: a systematic review and meta-analysis. BMJ Open. 2018 Aug 22;8(8):e022344.Full text external link opens in a new windowAbstract external link opens in a new window

45. Samokhvalov AV, Irving HM, Rehm J. Alcohol consumption as a risk factor for pneumonia: a systematic review and meta-analysis. Epidemiol Infect. 2010 Dec;138(12):1789-95.Abstract external link opens in a new window

46. Liu C, Cao Y, Lin J, et al. Oral care measures for preventing nursing home-acquired pneumonia. Cochrane Database Syst Rev. 2018 Sep 27;(9):CD012416.Full text external link opens in a new windowAbstract external link opens in a new window

47. Abramowitz J, Thakkar P, Isa A, et al. Adverse event reporting for proton pump inhibitor therapy: an overview of systematic reviews. Otolaryngol Head Neck Surg. 2016 Oct;155(4):547-54.Abstract external link opens in a new window

48. Lambert AA, Lam JO, Paik JJ, et al. Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis. PLoS One. 2015 Jun 4;10(6):e0128004.Full text external link opens in a new windowAbstract external link opens in a new window

49. Eom CS, Jeon CY, Lim JW, et al. Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis. CMAJ. 2011 Feb 22;183(3):310-9.Full text external link opens in a new windowAbstract external link opens in a new window

50. Almirall J, Bolíbar I, Serra-Prat M, et al. New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J. 2008 Jun;31(6):1274-84.Full text external link opens in a new windowAbstract external link opens in a new window

51. Schnoor M, Klante T, Beckmann M, et al. Risk factors for community-acquired pneumonia in German adults: the impact of children in the household. Epidemiol Infect. 2007 Nov;135(8):1389-97.Full text external link opens in a new windowAbstract external link opens in a new window

52. Teepe J, Grigoryan L, Verheij TJ. Determinants of community-acquired pneumonia in children and young adults in primary care. Eur Respir J. 2010 May;35(5):1113-7.Full text external link opens in a new windowAbstract external link opens in a new window

53. Yende S, van der Poll T, Lee M, et al. The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies. Thorax. 2010 Oct;65(10):870-7.Full text external link opens in a new windowAbstract external link opens in a new window

54. Kornum JB, Thomsen RW, Riis A, et al. Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study. Diabetes Care. 2008 Aug;31(8):1541-5.Full text external link opens in a new windowAbstract external link opens in a new window

55. Kang CI, Song JH, Kim SH, et al. Risk factors and pathogenic significance of bacteremic pneumonia in adult patients with community-acquired pneumococcal pneumonia. J Infect. 2013 Jan;66(1):34-40.Abstract external link opens in a new window

56. From S, Targowski T. The risk factors of death in community-acquired pneumonia [in Polish]. Pol Merkur Lekarski. 2002 Jun;12(72):455-7.Abstract external link opens in a new window

57. Chidiac C, Che D, Pires-Cronenberger S, et al. Factors associated with hospital mortality in community-acquired legionellosis in France. Eur Respir J. 2012 Apr;39(4):963-70.Full text external link opens in a new windowAbstract external link opens in a new window

58. Fernández J, Navasa M, Gómez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002 Jan;35(1):140-8.Full text external link opens in a new windowAbstract external link opens in a new window

59. Cillóniz C, Ewig S, Polverino E, et al. Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes. Clin Microbiol Infect. 2012 Nov;18(11):1134-42.Full text external link opens in a new windowAbstract external link opens in a new window

60. Edelman EJ, Gordon KS, Crothers K, et al. Association of prescribed opioids with increased risk of community-acquired pneumonia among patients with and without HIV. JAMA Intern Med. 2019 Mar 1;179(3):297-304.Abstract external link opens in a new window

61. Public Health England. Immunisation. Aug 2019 [internet publication].Full text external link opens in a new window

62. Public Health England. Pneumococcal: the green book, chapter 25. Jan 2018 [internet publication].Full text external link opens in a new window

63. Public Health England. Influenza: the green book, chapter 19. Apr 2019 [internet publication].Full text external link opens in a new window

64. National Institute for Health and Care Excellence. Pneumonia in adults: diagnosis and management. Sep 2019 [internet publication]. WITHDRAWN during COVID-19 pandemic.Full text external link opens in a new window

65. Hoare Z, Lim WS. Pneumonia: update on diagnosis and management. BMJ. 2006 May 6;332(7549):1077-9.Full text external link opens in a new windowAbstract external link opens in a new window

66. Daniels R, Nutbeam T, McNamara G, et al. The sepsis six and the severe sepsis resuscitation bundle: a prospective observational cohort study. Emerg Med J. 2011 Jun;28(6):507-12.Abstract external link opens in a new window

67. Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017 Mar;45(3):486-552.Full text external link opens in a new windowAbstract external link opens in a new window

68. Royal College of Physicians. National early warning score (NEWS) 2: standardising the assessment of acute-illness severity in the NHS. Dec 2017 [internet publication].Full text external link opens in a new window

69. Inada-Kim M. Introducing the suspicion of sepsis insights dashboard. Royal College of Pathologists Bulletin. 2019 Apr;186;109.

70. Surviving Sepsis Campaign. Hour-1 bundle. 2018 [internet publication].Full text external link opens in a new window

71. Lim WS, Rodrigo C, Turner AM, et al. British Thoracic Society community-acquired pneumonia care bundle: results of a national implementation project. Thorax. 2016 Mar;71(3):288-90.Abstract external link opens in a new window

72. Chu DK, Kim LH, Young PJ, et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. Lancet. 2018 Apr 28;391(10131):1693-705.Abstract external link opens in a new window

73. Stein PD, Afzal A, Henry JW, et al. Fever in acute pulmonary embolism. Chest. 2000 Jan;117(1):39-42.Abstract external link opens in a new window

74. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections: full version. Clin Microbiol Infect. 2011 Nov;17 Suppl 6:E1-59.Full text external link opens in a new windowAbstract external link opens in a new window

75. Durrington HJ, Summers C. Recent changes in the management of community acquired pneumonia in adults. BMJ. 2008 Jun 21;336(7658):1429-33.Full text external link opens in a new windowAbstract external link opens in a new window

76. Fulmer JD, Snider GL. American College of Chest Physicians/National Heart, Lung, and Blood Institute national conference on oxygen therapy. Heart Lung. 1984 Sep;13(5):550-62.Abstract external link opens in a new window

77. Marrie TJ. Coxiella burnetii pneumonia. Eur Respir J. 2003 Apr;21(4):713-9.Full text external link opens in a new windowAbstract external link opens in a new window

78. Mehr DR, Zweig SC, Kruse RL, et al. Mortality from lower respiratory infection in nursing home residents: a pilot prospective community-based study. J Fam Pract. 1998 Oct;47(4):298-304.Abstract external link opens in a new window

79. Norman DC. Pneumonia in the elderly: empiric antimicrobial therapy. Geriatrics. 1991 Dec;46(12):26-32.Abstract external link opens in a new window

80. Vergis EN, Brennen C, Wagener M, et al. Pneumonia in long-term care: a prospective case-control study of risk factors and impact on survival. Arch Intern Med. 2001 Oct 22;161(19):2378-81.Full text external link opens in a new windowAbstract external link opens in a new window

81. Baskaran V, Murray RL, Hunter A, et al. Effect of tobacco smoking on the risk of developing community acquired pneumonia: a systematic review and meta-analysis. PLoS One. 2019 Jul 18;14(7):e0220204.Full text external link opens in a new windowAbstract external link opens in a new window

82. Rodriguez F, Bolíbar I, Serra-Prat M, et al. Poor oral health as risk factor for community-acquired pneumonia. J Pulm Respir Med. 2014 Sep 26;4(5):1000203.Full text external link opens in a new window

83. Kanwar M, Brar N, Khatib R, et al. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest. 2007 Jun;131(6):1865-9.Abstract external link opens in a new window

84. Müller NL, Franquet T, Lee KS. In: McAllister L, ed. Imaging of pulmonary infections. Philadelphia, PA: Wolters Kluwer/Lipponcott Williams & Wilkins; 2007.

85. Sahn SA. Diagnosis and management of parapneumonic effusions and empyema. Clin Infect Dis. 2007 Dec;45(11):1480-6.Full text external link opens in a new windowAbstract external link opens in a new window

86. Webb WR, Higgins CB. Thoracic imaging: pulmonary and cardiovascular radiology. Lippincott Williams & Wilkins; 2010.

87. Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014 Nov 14;35(43):3033-69.Full text external link opens in a new windowAbstract external link opens in a new window

88. Long L, Zhao HT, Zhang ZY, et al. Lung ultrasound for the diagnosis of pneumonia in adults: a meta-analysis. Medicine (Baltimore). 2017 Jan;96(3):e5713.Full text external link opens in a new windowAbstract external link opens in a new window

89. O'Driscoll BR, Howard LS, Earis J, et al. BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017 Jun;72 (Suppl 1):ii1-90.Abstract external link opens in a new window

90. Woodhead M. New guidelines for the management of adult lower respiratory tract infections. Eur Respir J. 2011 Dec;38(6):1250-1.Full text external link opens in a new windowAbstract external link opens in a new window

91. Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med. 2008 Mar;121(3):219-25.Abstract external link opens in a new window

92. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis. 1989 Jul-Aug;11(4):586-99.Abstract external link opens in a new window

93. Corbo J, Friedman B, Bijur P, et al. Limited usefulness of initial blood cultures in community acquired pneumonia. Emerg Med J. 2004 Jul;21(4):446-8.Full text external link opens in a new windowAbstract external link opens in a new window

94. Anevlavis S, Petroglou N, Tzavaras A, et al. A prospective study of the diagnostic utility of sputum Gram stain in pneumonia. J Infect. 2009 Aug;59(2):83-9.Abstract external link opens in a new window

95. Smith MD, Derrington P, Evans R, et al. Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation. J Clin Microbiol. 2003 Jul;41(7):2810-3.Full text external link opens in a new windowAbstract external link opens in a new window

96. Lim WS, Smith DL, Wise MP, et al. British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together. Thorax. 2015 Jul;70(7):698-700.Full text external link opens in a new windowAbstract external link opens in a new window

97. Birtles RJ, Harrison TG, Samuel D, et al. Evaluation of urinary antigen ELISA for diagnosing Legionella pneumophila serogroup 1 infection. J Clin Pathol. 1990 Aug;43(8):685-90.Full text external link opens in a new windowAbstract external link opens in a new window

98. Du Rand IA, Blaikley J, Booton R, et al. British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE. Thorax. 2013 Aug;68 Suppl 1:i1-44.Full text external link opens in a new windowAbstract external link opens in a new window

99. Marrie TJ. Community-acquired pneumonia. Clin Infect Dis. 1994 Apr;18(4):501-13.Abstract external link opens in a new window

100. Perrier A, Roy PM, Sanchez O, et al. Multidetector-row computed tomography in suspected pulmonary embolism. N Engl J Med. 2005 Apr 28;352(17):1760-8.Full text external link opens in a new windowAbstract external link opens in a new window

101. National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community. April 2020 [internet publication].Full text external link opens in a new window

102. O'Connor AR, Morgan WE. Radiological review of pneumothorax. BMJ. 2005 Jun 25;330(7506):1493-7.Full text external link opens in a new windowAbstract external link opens in a new window

103. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003 May;58(5):377-82.Full text external link opens in a new windowAbstract external link opens in a new window

104. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997 Jan 23;336(4):243-50.Full text external link opens in a new windowAbstract external link opens in a new window

105. National Institute for Health and Care Excellence. Pneumonia (community-acquired): antimicrobial prescribing. Sep 2019 [internet publication].Full text external link opens in a new window

106. Luna HI, Pankey G. The utility of blood culture in patients with community-acquired pneumonia. Ochsner J. 2001 Apr;3(2):85-93.Full text external link opens in a new windowAbstract external link opens in a new window

107. Shah BA, Ahmed W, Dhobi GN, et al. Validity of pneumonia severity index and CURB-65 severity scoring systems in community acquired pneumonia in an Indian setting. Indian J Chest Dis Allied Sci. 2010 Jan-Mar;52(1):9-17.Abstract external link opens in a new window

108. Aujesky D, Auble TE, Yealy DM, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med. 2005 Apr;118(4):384-92.Abstract external link opens in a new window

109. British Thoracic Society; Myint PK, Kamath AV, Vowler SL, et al. Severity assessment criteria recommended by the British Thoracic Society (BTS) for community-acquired pneumonia (CAP) and older patients: should SOAR (systolic blood pressure, oxygenation, age and respiratory rate) criteria be used in older people? A compilation study of two prospective cohorts. Age Ageing. 2006 May;35(3):286-91.Full text external link opens in a new windowAbstract external link opens in a new window

110. Capelastegui A, España PP, Quintana JM, et al. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J. 2006 Jan;27(1):151-7.Full text external link opens in a new windowAbstract external link opens in a new window

111. Zhang ZX, Zhang W, Liu P, et al. Prognostic value of pneumonia severity index, CURB-65, CRB-65, and procalcitonin in community-acquired pneumonia in Singapore. PoSH. 2016 Sep;25(3):139–47.Full text external link opens in a new window

112. Uranga A, España PP, Bilbao A, et al. Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial. JAMA Intern Med. 2016 Sep 1;176(9):1257-65.Abstract external link opens in a new window

113. European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. Mar 2019 [internet publication].Full text external link opens in a new window

114. Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects. Mar 2019 [internet publication].Full text external link opens in a new window

115. Beasley R, Chien J, Douglas J, et al. Thoracic Society of Australia and New Zealand oxygen guidelines for acute oxygen use in adults: 'swimming between the flags'. Respirology. 2015 Nov;20(8):1182-91.Full text external link opens in a new windowAbstract external link opens in a new window

116. Siemieniuk RAC, Chu DK, Kim LH, et al. Oxygen therapy for acutely ill medical patients: a clinical practice guideline. BMJ. 2018 Oct 24;363:k4169.Abstract external link opens in a new window

117. Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign bundle: 2018 update. Crit Care Med. 2018 Jun;46(6):997-1000.Abstract external link opens in a new window

118. Stern A, Skalsky K, Avni T, et al. Corticosteroids for pneumonia. Cochrane Database Syst Rev. 2017 Dec 13;(12):CD007720.Full text external link opens in a new windowAbstract external link opens in a new window

119. Horita N, Otsuka T, Haranaga S, et al. Adjunctive systemic corticosteroids for hospitalized community-acquired pneumonia: systematic review and meta-analysis 2015 update. Sci Rep. 2015 Sep 16;5:14061.Full text external link opens in a new windowAbstract external link opens in a new window

120. Siemieniuk RA, Meade MO, Alonso-Coello P, et al. Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis. Ann Intern Med. 2015 Oct 6;163(7):519-28.Abstract external link opens in a new window

121. Capelastegui A, España PP, Bilbao A, et al. Pneumonia: criteria for patient instability on hospital discharge. Chest. 2008 Sep;134(3):595-600.Abstract external link opens in a new window

122. Niederman M. In the clinic: community-acquired pneumonia. Ann Intern Med. 2009 Oct 6;151(7):ITC42-14.Abstract external link opens in a new window

123. Torres A, Cillóniz C, Ferrer M, et al. Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis. Eur Respir J. 2015 May;45(5):1353-63.Abstract external link opens in a new window

124. Sligl WI, Marrie TJ. Severe community-acquired pneumonia. Crit Care Clin. 2013 Jul;29(3):563-601.Abstract external link opens in a new window

125. Melzer M, Welch C. 30-day mortality in UK patients with bacteraemic community-acquired pneumonia. Infection. 2013 Oct;41(5):1005-11.Abstract external link opens in a new window

126. O'Driscoll BR, Howard LS, Earis J, et al; British Thoracic Society Emergency Oxygen Guideline Group; BTS Emergency Oxygen Guideline Development Group. BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017 Jun;72(suppl 1):ii1-90Abstract external link opens in a new window

127. British Thoracic Society; Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. July 2019 [internet publication].Full text external link opens in a new window

128. Chu DK, Kim LH, Young PJ, et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): systematic review and meta-analysis. Lancet. 2018 Apr 26;391(10131):1693-1705Abstract external link opens in a new window

129. Siemieniuk RAC, Chu DK, Kim LH, et al. Oxygen therapy for acutely ill medical patients: a clinical practice guideline. BMJ. 2018 Oct 24;363:k4169Full text external link opens in a new windowAbstract external link opens in a new window

130. National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital. Clinical guideline CG174. May 2017 [internet publication]Full text external link opens in a new window

131. Verbrugge FH, Grieten L, Mullens W. Management of the cardiorenal syndrome in decompensated heart failure. Cardiorenal Med. 2014 Dec;4(3-4):176-88Full text external link opens in a new windowAbstract external link opens in a new window

132. Fritz Z, Slowther AM, Perkins GD. Resuscitation policy should focus on the patient, not the decision. BMJ. 2017 Feb 28;356:j813Full text external link opens in a new windowAbstract external link opens in a new window

133. The National Institute for Health and Care Excellence. Decision making and mental capacity. October 2018 [internet publication]Full text external link opens in a new window

134. Department of Health. Mental Capacity Act 2005 [internet publication]Full text external link opens in a new window

135. Social Care Institute for Excellence. Independent mental capacity advocate (IMCA). 2011 [internet publication]Full text external link opens in a new window

136. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016 May 20;37(27):2129-200Full text external link opens in a new windowAbstract external link opens in a new window

137. Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011 Apr;21(2):69-72Abstract external link opens in a new window

138. Chowdhury TA, Cheston H, Claydon A. Managing adults with diabetes in hospital during an acute illness. BMJ. 2017 Jun 22;357:j2551Full text external link opens in a new windowAbstract external link opens in a new window

139. Joint British Diabetes Societies for inpatient care. The use of variable rate intravenous insulin infusion (VRIII) in medical inpatients. October 2014 [internet publication]Full text external link opens in a new window

140. Joint British Diabetes Societies for inpatient care. Management of adults with diabetes undergoing surgery and elective procedures: Improving standards. Revised March 2016 [internet publication]Full text external link opens in a new window

141. British National Formulary 77. Metformin hydrochloride. London: BMJ Group, RCPCH Publications Ltd and the Royal Pharmaceutical Society of Great Britain. July 2020Full text external link opens in a new window

142. Medicines and Healthcare products Regulatory Agency. SGLT2 inhibitors: monitor ketones in blood during treatment interruption for surgical procedures or acute serious medical illness. March 2020 [internet publication]Full text external link opens in a new window

143. Peters AL, Buschur EO, Buse JB, et al. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015 Jun 15;38(9):1687-93Abstract external link opens in a new window

144. Joint British Diabetes Societies Inpatient Care Group. The management of diabetic ketoacidosis in adults. 2nd ed. September 2013 [internet publication]Full text external link opens in a new window

145. National Institute for Health and Care Excellence. Acute kidney injury: prevention, detection and management. December 2019 [internet publication]Full text external link opens in a new window

146. Hsu CY, Ordoñez JD, Chertow GM, et al. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int. 2008 Apr 2;74(1):101-7Full text external link opens in a new windowAbstract external link opens in a new window

147. Grau AJ, Urbanek C, Palm F. Common infections and the risk of stroke. Nat Rev Neurol. 2010 Nov 9;6(12):681-94Abstract external link opens in a new window

148. Eigenbrodt ML, Rose KM, Couper DJ, et al. Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996. Stroke. 2000 Oct;31(10):2307-13Abstract external link opens in a new window

149. Winstein CJ, Stein J, Arena R, et al. Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2016 May 4;47(6):e98-e169Full text external link opens in a new windowAbstract external link opens in a new window

150. Pendlebury ST, Klaus SP, Mather M, et al. Routine cognitive screening in older patients admitted to acute medicine: abbreviated mental test score (AMTS) and subjective memory complaint versus Montreal Cognitive Assessment and IQCODE. Age Ageing. 2015 Oct 13;44(6):1000-5Full text external link opens in a new windowAbstract external link opens in a new window

151. Hodkinson HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing. 1972 Nov;1(4):233-8Abstract external link opens in a new window

152. The National Institute for Health and Clinical Excellence. Delirium: diagnosis, prevention and management. (CG103). March 2019 [internet publication]Full text external link opens in a new window

153. The National Institute for Health and Clinical Excellence. Dementia: assessment, management and support for people living with dementia and their carers. June 2018 [internet publication]Full text external link opens in a new window

154. Scottish Intercollegiate Guidelines Network. Risk reduction and management of delirium. March 2019 [internet publication]Full text external link opens in a new window

155. Nova Scotia Health Authority. This is not my Mom. 2012 [internet publication]Full text external link opens in a new window

156. Inouye SK, Schlesinger MJ, Lydon TJ. Delirium: a symptom of how hospital care is failing older persons and a window to improve quality of hospital care. Am J Med. 1999 May;106(5):565-73Abstract external link opens in a new window

157. Bellelli G, Morandi A, Davis DH, et al. Validation of the 4AT, a new instrument for rapid delirium screening: a study in 234 hospitalised older people. Age Ageing. 2014 Mar 2;43(4):496-502Full text external link opens in a new windowAbstract external link opens in a new window

158. MacLullich AM, Shenkin SD, Goodacre S, et al. The 4 'A's test for detecting delirium in acute medical patients: a diagnostic accuracy study. Health Technol Assess. 2019 Aug;23(40):1-194Full text external link opens in a new windowAbstract external link opens in a new window

159. White S, Griffiths R, Baxter M, et al. Guidelines for the peri-operative care of people with dementia: guidelines from the Association of Anaesthetists. Anaesthesia. 2019 Jan 11;74(3):357-72Full text external link opens in a new windowAbstract external link opens in a new window

160. Siddiqi N, Harrison JK, Clegg A, et al. Interventions for preventing delirium in hospitalised non-ICU patients. Cochrane Database Syst Rev. 2016 Mar 11;3:CD005563Full text external link opens in a new windowAbstract external link opens in a new window

161. Martinez F, Tobar C, Hill N. Preventing delirium: should non-pharmacological, multicomponent interventions be used? A systematic review and meta-analysis of the literature. Age Ageing. 2014 Nov 25;44(2):196-204Full text external link opens in a new windowAbstract external link opens in a new window

162. Public Health England. Urinary tract infection: diagnostic tools for primary care. September 2019 [internet publication]Full text external link opens in a new window

163. Pryor C, Clarke A. Nursing care for people with delirium superimposed on dementia. Nurs Older People. 2017 Mar 31;29(3):18-21Full text external link opens in a new windowAbstract external link opens in a new window

164. Ma H, Huang Y, Cong Z, et al. The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials. J Alzheimers Dis. 2014;42(3):915-37Abstract external link opens in a new window

165. Huybrechts KF, Gerhard T, Crystal S, et al. Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. BMJ. 2012 Feb 23;344:e977Full text external link opens in a new windowAbstract external link opens in a new window

166. Van Leeuwen E, Petrovic M, van Driel ML, et al. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2018 Mar 30;3:CD007726Full text external link opens in a new windowAbstract external link opens in a new window

167. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13Abstract external link opens in a new window

168. Boden JM, Fergusson DM. Alcohol and depression. Addiction. 2011 Mar 7;106(5):906-14Full text external link opens in a new windowAbstract external link opens in a new window

169. American Diabetes Association. 15. Diabetes care in the hospital: standards of medical care in diabetes - 2020. Diabetes Care. 2020 Jan;43(suppl 1):S193-S202Full text external link opens in a new windowAbstract external link opens in a new window

170. NHS Digital. National Diabetes Inpatient Audit (NaDIA) - 2017. March 2018 [internet publication]Full text external link opens in a new window

171. Joint British Diabetes Societies for inpatient care. Self-management of diabetes in hospital. March 2012 [internet publication]Full text external link opens in a new window

172. National Institute for Health and Care Excellence. Type 1 diabetes in adults: diagnosis and management. July 2016 [internet publication]Full text external link opens in a new window

173. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009 May-Jun;15(4):353-69Abstract external link opens in a new window

174. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 Nov 8;345(19):1359-67Full text external link opens in a new windowAbstract external link opens in a new window

175. NICE-SUGAR Study Investigators; Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 Mar 26;360(13):1283-97.Full text external link opens in a new windowAbstract external link opens in a new window

176. Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest. 2009 Dec 16;137(3):544-51Full text external link opens in a new windowAbstract external link opens in a new window

177. Joint British Diabetes Societies for inpatient care. The management of the hyperosmolar hyperglycaemic state (HHS) in adults with diabetes. August 2012 [internet publication]Full text external link opens in a new window

178. Rehman A, Setter SM, Vue MH. Drug-induced glucose alterations part 2: drug-Induced hyperglycemia. Diabetes Spect. 2011 Nov;24(4):234-8Full text external link opens in a new window

179. Joint British Diabetes Societies for inpatient care. The hospital management of hypoglycaemia in adults with diabetes mellitus. 4th ed. January 2020 [internet publication]Full text external link opens in a new window

180. Rowles S, Kilvert A, Sinclair A; on behalf of the Association of British Clinical Diabetologists (ABCD). ABCD position statement on diabetes and end of life care. Pract Diab Int, 2011;28:26-7Full text external link opens in a new window

181. National Institute for Health and Care Excellence. Diabetic foot problems: prevention and management. October 2019 [internet publication]Full text external link opens in a new window

182. Rayman G, Vas PR, Baker N, et al. The Ipswich Touch Test: a simple and novel method to identify inpatients with diabetes at risk of foot ulceration. Diabetes Care. 2011 May 18;34(7):1517-8Full text external link opens in a new windowAbstract external link opens in a new window

183. Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest. 2004 Jun;125(6):2309-21Full text external link opens in a new windowAbstract external link opens in a new window

184. Au DH, Curtis JR, Every NR, et al. Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction. Chest. 2002 Mar;121(3):846-51Full text external link opens in a new windowAbstract external link opens in a new window

185. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. 2020 [internet publication]Full text external link opens in a new window

186. Walters JA, Tan DJ, White CJ, et al. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2018 Mar 19;3:CD006897Full text external link opens in a new windowAbstract external link opens in a new window

187. Cleare A, Pariante CM, Young AH, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2015 May 12;29(5):459-525Full text external link opens in a new windowAbstract external link opens in a new window

188. National Institute for Health and Care Excellence. Depression in adults with a chronic physical health problem: recognition and management. October 2009 [internet publication]Full text external link opens in a new window

189. Taylor DM, Barnes TRE, Young AH. The Maudsley prescribing guidelines in psychiatry. 13th edition. Chichester: Wiley-Blackwell; 2018

190. Flowers L. Nicotine replacement therapy. Am J Psychiatry Resid. 2016 Jun;11(6)4-7Full text external link opens in a new window

191. Desai HD, Seabolt J, Jann MW. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs. 2001;15(6):469-94

192. Oliveira P, Ribeiro J, Donato H, Madeira N. Smoking and antidepressants pharmacokinetics: a systematic review. Ann Gen Psychiatry. 2017;16:17Full text external link opens in a new windowAbstract external link opens in a new window

193. National Centre for smoking cessation and training. Smoking cessation and mental health. 2014 [internet publication].Full text external link opens in a new window

194. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005 Mar 17;352(11):1112-20Abstract external link opens in a new window

195. Auerbach AD, Vittinghoff E, Maselli J, et al. Perioperative use of selective serotonin reuptake inhibitors and risks for adverse outcomes of surgery. JAMA Intern Med. 2013 Jun 24;173(12):1075-81Full text external link opens in a new windowAbstract external link opens in a new window

196. National Institute for Health and Care Excellence. Liaison psychiatry. In: Emergency acute medical care in over 16s: service delivery and organisation. March 2018 [internet publication]Full text external link opens in a new window

197. National Confidential Enquiry into Patient Outcome and Death (NCEPOD). Treat as one. Bridging the gap between mental and physical healthcare in general hospitals. 2017 [internet publication]Full text external link opens in a new window

198. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000 Jul 24;160(14):2101-7Abstract external link opens in a new window

199. Clarke DM, Currie KC. Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence. Med J Aust. 2009 Apr 6;190(7 suppl):S54-60Abstract external link opens in a new window

200. Prina AM, Cosco TD, Dening T, et al. The association between depressive symptoms in the community, non-psychiatric hospital admission and hospital outcomes: a systematic review. J Psychosom Res. 2014 Nov 8;78(1):25-33Full text external link opens in a new windowAbstract external link opens in a new window

201. World Health Organization. Excess mortality in persons with severe mental disorders. 2016 [internet publication]Full text external link opens in a new window

202. National Institute for Health and Care Excellence. Smoking: acute, maternity and mental health services. Public health guideline [PH48]. November 2013 [internet publication]Full text external link opens in a new window

203. Farazi A, Sofian M, Jabbariasl M, et al. Coenzyme q10 administration in community-acquired pneumonia in the elderly. Iran Red Crescent Med J. 2014 Dec 1;16(12):e18852.Full text external link opens in a new windowAbstract external link opens in a new window

204. El Hajj MS, Turgeon RD, Wilby KJ. Ceftaroline fosamil for community-acquired pneumonia and skin and skin structure infections: a systematic review. Int J Clin Pharm. 2017 Feb;39(1):26-32.Abstract external link opens in a new window

205. Taboada M, Melnick D, Iaconis JP, et al. Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2016 Apr;71(4):862-70.Abstract external link opens in a new window

206. Nicholson SC, Welte T, File TM Jr, et al. A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation. Int J Antimicrob Agents. 2012 Mar;39(3):240-6.Abstract external link opens in a new window

207. Liu Y, Zhang Y, Wu J, et al.  A randomized, double-blind, multicenter phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia. J Microbiol Immunol Infect. 2017 Dec;50(6):811-20.Abstract external link opens in a new window

208. Oldach D, Clark K, Schranz J, et al. Randomized, double-blind, multicenter phase 2 study comparing the efficacy and safety of oral solithromycin (CEM-101) to those of oral levofloxacin in the treatment of patients with community-acquired bacterial pneumonia. Antimicrob Agents Chemother. 2013 Jun;57(6):2526-34.Full text external link opens in a new windowAbstract external link opens in a new window

209. File TM Jr, Rewerska B, Vucinic-Mihailovic V, et al. SOLITAIRE-IV: a randomized, double-blind, multicenter study comparing the efficacy and safety of intravenous-to-oral solithromycin to intravenous-to-oral moxifloxacin for treatment of community-acquired bacterial pneumonia. Clin Infect Dis. 2016 Oct 15;63(8):1007-16.Full text external link opens in a new windowAbstract external link opens in a new window

210. Putnam SD, Castanheira M, Moet GJ, et al. CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria. Diagn Microbiol Infect Dis. 2010 Apr;66(4):393-401.Abstract external link opens in a new window

211. Jasti H, Mortensen EM, Obrosky DS, et al. Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia. Clin Infect Dis. 2008 Feb 15;46(4):550-6.Full text external link opens in a new windowAbstract external link opens in a new window

212. Capelastegui A, España Yandiola PP, Quintana JM, et al. Predictors of short-term rehospitalization following discharge of patients hospitalized with community-acquired pneumonia. Chest. 2009 Oct;136(4):1079-85.Abstract external link opens in a new window

213. Viasus D, Del Rio-Pertuz G, Simonetti AF, et al. Biomarkers for predicting short-term mortality in community-acquired pneumonia: a systematic review and meta-analysis. J Infect. 2016 Mar;72(3):273-82.Abstract external link opens in a new window

214. Corrales-Medina VF, Suh KN, Rose G, et al. Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med. 2011 Jun;8(6):e1001048.Full text external link opens in a new windowAbstract external link opens in a new window

215. Becker T, Moldoveanu A, Cukierman T, et al. Clinical outcomes associated with the use of subcutaneous insulin-by-glucose sliding scales to manage hyperglycemia in hospitalized patients with pneumonia. Diabetes Res Clin Pract. 2007 Dec;78(3):392-7.Abstract external link opens in a new window

216. Ramirez J, Aliberti S, Mirsaeidi M, et al. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis. 2008 Jul 15;47(2):182-7.Full text external link opens in a new windowAbstract external link opens in a new window

217. Corrales-Medina VF, Serpa J, Rueda AM, et al. Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes. Medicine (Baltimore). 2009 May;88(3):154-9.Abstract external link opens in a new window

218. Light RW, Girard WM, Jenkinson SG, et al. Parapneumonic effusions. Am J Med. 1980 Oct;69(4):507-12.Abstract external link opens in a new window

219. Taryle DA, Potts DE, Sahn SA. The incidence and clinical correlates of parapneumonic effusions in pneumococcal pneumonia. Chest. 1978 Aug;74(2):170-3.Abstract external link opens in a new window

220. Menéndez R, Torres A, Zalacaín R, et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax. 2004 Nov;59(11):960-5.Full text external link opens in a new windowAbstract external link opens in a new window

221. Tsai YF, Ku YH. Necrotizing pneumonia: a rare complication of pneumonia requiring special consideration. Curr Opin Pulm Med. 2012 May;18(3):246-52.Abstract external link opens in a new window

Use of this content is subject to our disclaimer